METABOLIC ALTERATIONS IN GLYCOLIPIDS DURING ACUTE KIDNEY INJURY DRIVE RENAL INFLAMMATION

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/fe895c9242432069e0540d25ed00aba7.pdf
METABOLIC ALTERATIONS IN GLYCOLIPIDS DURING ACUTE KIDNEY INJURY DRIVE RENAL INFLAMMATION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
AKINORI
OSADA
AKINORI OSADA osada.akinori.d3@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Department of Nephrology Nagoya Japan *
MIYAKO TANAKA tanaka@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Kyoto Japan -
YUKI SUGIURA yuki.sgi@gmail.com Graduate School of Medicine, Kyoto University Center for Cancer Immunotherapy and Immunobiology Nagoya Japan -
XUNMEI YUAN xmyuan@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Nagoya Japan -
KOZUE OCHI ochi-k@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Nagoya Japan -
HIRO KOHDA hkohda@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Nagoya Japan -
AYAKA ITO aito@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Nagoya Japan -
MOTOKO YANAGITA motoy@kuhp.kyoto-u.ac.jp Graduate School of Medicine, Kyoto University Department of Nephrology Kyoto Japan -
KAZUHIRO FURUHASHI furuhashi.kazuhiro.z0@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Department of Nephrology Nagoya Japan -
SHOICHI MARUYAMA maruyama.shoichi.y5@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Department of Nephrology Nagoya Japan -
TAKAYOSHI SUGANAMI suganami@riem.nagoya-u.ac.jp Research Institute of Environmental Medicine, Nagoya University Department of Molecular Medicine and Metabolism Nagoya Japan -
-
-
-
-